Treprostinil for the treatment of pulmonary hypertension
AssigneeInvox Belgium NV
InventorsIsabel d’Orey Marchand Sequeira Lopes Beirão Belo, Juergen Rawert
Life of this patent
Estimating the term…
Loading patent…
AssigneeInvox Belgium NV
InventorsIsabel d’Orey Marchand Sequeira Lopes Beirão Belo, Juergen Rawert
Estimating the term…
Treprostinil or a pharmaceutically acceptable salt or derivative thereof may be used in treating pulmonary hypertension in a subject at risk of developing pulmonary hypertension. The treatment may include administering to the subject a first liquid composition comprising Treprostinil or a pharmaceutically acceptable salt or derivative thereof in a first concentration in aerosolized form for a first treatment period, and administering to said subject a second liquid composition comprising Treprostinil or a pharmaceutically acceptable salt or derivative thereof in a second concentration in aerosolized form for a second treatment period following the first treatment period. The second concentration of the second liquid composition may be higher than the first concentration in the first liquid composition. The liquid compositions are administered using a soft mist inhaler.
A method of treating or preventing pulmonary hypertension in a subject, the method comprising:
(canceled)
(canceled)
(canceled)
22-23. (Canceled)
26-35. (canceled)
Dependencies are inferred from the claim text.